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Abstract
The penC resistance gene was previously characterized in a FA19 penA mtrR penB gonococcal strain
(PR100) as a spontaneous mutation that increased resistance to penicillin and tetracycline. We show
here that antibiotic resistance mediated by penC is the result of a Glu-666 to Lys missense mutation
in the pilQ gene that interferes with the formation of the SDS-resistant high-molecular-mass PilQ
secretin complex, disrupts piliation, and decreases transformation frequency by 50-fold. Deletion of
pilQ in PR100 confers the same level of antibiotic resistance as the penC mutation, but increased
resistance was observed only in strains containing the mtrR and penB resistance determinants. Site-
saturation mutagenesis of Glu-666 revealed that only acidic or amidated amino acids at this position
preserved PilQ function. Consistent with early studies suggesting the importance of cysteine residues
on stability of the PilQ multimer, mutation of either of the two cysteine residues in FA19 PilQ led
to a similar phenotype as penC: increased antibiotic resistance, loss of piliation, intermediate levels
of transformation competence, and absence of SDS-resistant PilQ oligomers. These data show that
a functional secretin complex can enhance the entry of antibiotics into the cell and suggest that the
PilQ oligomer forms a pore in the outer membrane through which antibiotics diffuse into the
periplasm.
INTRODUCTION
For nearly 30 years, sexually transmitted infections caused by Neisseria gonorrhoeae were
routinely treated with penicillin. During that time, however, clinical isolates gradually became
more resistant until treatment failure occurred and penicillin was discontinued as a therapeutic
agent. Resistance to penicillin in the gonococci occurs by two routes: the plasmid-encoded
production of a TEM-1-like ß-lactamase, and multiple chromosomally mediated mutations that
increase resistance in a stepwise manner (Cannon and Sparling, 1984). As shown in an elegant
series of studies by Sparling and colleagues, chromosomally mediated resistance genes can be
transferred from a high-level resistant strain (e.g. FA6140) to a susceptible strain (e.g. FA19)
by transformation and homologous recombination (Maness and Sparling, 1973; Sarubbi et
al., 1974).
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The mechanisms underlying chromosomally mediated penicillin resistance in the gonococci
are complex and not fully understood. Multiple gene mutations are required for high-level
resistance, but none of these mutations increases resistance dramatically. Only when these
mutations are combined do they increase resistance to levels above that achieved clinically.
There are five gene mutations known to contribute to high-level penicillin resistance (Minimum
Inhibitory Concentration (MIC) ≥ 2 μg/ml) in chromosomally mediated resistant N.
gonorrhoeae (CMRNG) strains (Ropp et al., 2002), and these genes are transferred from a
resistant strain to a susceptible strain in a specific order. The first resistance determinant
transferred is penA, which encodes altered forms of penicillin-binding protein 2 (PBP 2) with
decreased rates of acylation by penicillin (Brannigan et al., 1990; Dowson et al., 1989). The
second resistance locus transferred is mtrR, which carries a mutation in the promoter region of
the MtrR repressor that abolishes transcription of the mtrR gene and results in overexpression
of the MtrC-MtrD-MtrE efflux pump (Hagman et al., 1995; Pan and Spratt, 1994).
Overexpression of the MtrC-MtrD-MtrE efflux pump increases penicillin resistance only
slightly, but is required for further increases in resistance mediated by subsequent resistance
genes (Hagman et al., 1997; Veal et al., 2002). The third resistance determinant transferred,
designated penB, corresponds to porin alleles carrying mutations on loop 3 that decrease the
concentration of antibiotics in the periplasmic space (Gill et al., 1998; Olesky et al., 2002).
Transformation of a third-level resistant strain (FA19 penA mtrR penB) to a higher level of
resistance is very difficult to achieve in the laboratory (Dougherty, 1986; Faruki and Sparling,
1986). We previously investigated the role of the ponA gene encoding PBP 1, the other essential
PBP in N. gonorrhoeae, in high-level penicillin resistance (Ropp and Nicholas, 1997; Ropp
et al., 2002). The ponA gene from high-level penicillin-resistant strains contains a single base
mutation that decreases the rate of acylation of PBP 1 by 3- to 4-fold. Reversion of the mutant
ponA allele (ponA1) back to the wild type sequence in the CMRNG strain FA6140 decreased
the MIC for penicillin by 2-fold, conclusively demonstrating that ponA1 is involved in high
level resistance. However, additional determinants are required to enable ponA1 to increase
resistance, since no increase in resistance was observed when ponA1 was transferred to PR100
(FA19 penA mtrR penB), a third-level transformant strain.
In a search for additional mutations that would increase resistance above that conferred by the
first three determinants, we identified a mutation, termed penC, that increased resistance to
both penicillin and tetracycline (Ropp et al., 2002). Resistance due to penC is the result of a
spontaneous mutation and is readily transferable between strains. Surprisingly, introduction of
the ponA1 allele into PR100 increased resistance two-fold, indicating that the penC allele
conferred the ability to increase resistance to ponA1 strains. However, the absence of penC in
CMRNG strains suggests that clinical isolates use another as yet undetermined mechanism to
further increase resistance levels.
In this report, we show that the increased resistance due to penC is the result of a point mutation
in the pilQ gene (pilQ2). PilQ (previously known as Outer Membrane Protein-Macromolecular
Complex or OMP-MC), a member of the secretin family of proteins, is a major component of
the gonococcal outer membrane (Newhall et al., 1980). PilQ is required for formation of the
Type IV pilus, which is involved in twitching motility, cell attachment and invasion of epithelia,
and DNA transformation (Tonjum and Koomey, 1997). PilQ forms a ring-shaped multimeric
complex, most likely a dodecamer (Collins et al., 2001), with the pilus formed by a repeating
polymer of pilin subunits protruding from the central cavity (Collins et al., 2003; Collins et
al., 2004). The pilQ2 mutation disrupts the formation of an SDS-resistant multimeric complex,
causes a loss of piliation, and decreases transformation competence by 50-fold. Increased
resistance to a wide range of antibiotics due to acquisition of pilQ2 is observed only in strains
containing the mtrR and penB resistance determinants. The increase in MICs of a variety of
Zhao et al. Page 2













antibiotics in these strains highlights the importance of a functional PilQ multimer in the entry
of antibiotics into the cell.
RESULTS
Antibiotic resistance due to penC is the result of a point mutation in pilQ
We previously reported the isolation of spontaneously arising colonies of PR100 (FA19 penA
mtrR penB; see Table 1) having 2-fold increases in the MICs for both penicillin and tetracycline
(Ropp et al., 2002). This mutation, termed penC, was not due to additional mutations in the
penA, mtrR, or penB genes. Because genomic DNA from PR100 penC transformed PR100 to
increased penicillin resistance with high frequency, we cloned the penC gene by generating a
size-fractionated ClaI plasmid library of genomic DNA from one of the PR100 penC colonies
and identifying plasmids capable of transforming PR100 to increased penicillin resistance (see
Materials and Methods for more details). Three individual clones were identified that harbored
a plasmid with an identical 10.6 kb insert. Transformation experiments with PCR fragments
amplified from the DNA insert localized the penC mutation to the pilQ gene, and sequencing
of the pilQ gene revealed that the penC phenotype was the result of a single G to A mutation
at nucleotide 1996 in the pilQ gene that changes Glu-666 to Lys (numbering from the initiating
methionine). We refer to the penC allele hereafter as pilQ2.
Effect of pilQ2 on pilus formation and transformation efficiency
Transformation of PR100 with pUC18-pilQ2 plasmid DNA to increased penicillin resistance
resulted in a nonpiliated colony morphology, but how pilQ2 influences pilus formation was
unclear. Thus, we generated isogenic strains of RM11.2 recA6, a defined pilin variant of strain
FA1090 (Long et al., 2001) with a regulatable recA gene that allows for IPTG control of pilin
antigenic variation (Seifert, 1997), containing either the FA19 pilQ allele (pilQFA19; FA19 and
FA1090 PilQ differ by two amino acids in the C-terminal domain) or the pilQ2 allele. We
examined the piliation state of these strains by immunogold transmission electron microscopy
with an anti-pilin peptide antibody (Long et al., 2003). All of the RM11.2 recA6 derivatives
were confirmed to have identical pilE sequences, which assured that differences in piliation
were not due to pilin variation. Approximately 50% of RM11.2 recA6 or RM11.2 recA6
pilQFA19 cells had pili and the majority of pili were in bundles (Fig. 1A, left and middle panels).
In contrast, two independently derived RM11.2 recA6 pilQ2 mutants had no observable distinct
pili on 955 cells examined (Fig. 1A, right panel). However, in a small number of RM11.2
recA6 pilQ2 cells (∼0.6%), we observed short, membrane-attached projections that interacted
specifically with the anti-pilin antibody (Fig. 1B). These projections did not have the same
morphology as pili (Fig. 1A) and therefore represent an alternative expression of the pilin
protein on the cell surface of pilQ2 strains.
We also examined the effect of the pilQ2 mutation on transformation competence. The
transformation frequency of a gyrB allele encoding resistance to nalidixic acid (Stein et al.,
1991) was determined with SZ3 (RM11.2 recA6penA mtrR penB; see Table 1) alone and SZ3
harboring either the pilQ2, ΔpilE, pilT::erm, or pilQ::Ω alleles. As shown in Fig. 2, the
pilQ2 allele resulted in a 50-fold reduction in transformation frequency, whereas the pilT,
pilE, and pilQ::Ω alleles reduced the transformation frequency to ≤1 × 10−6. Thus, although
the pilQ2 mutation appears to disrupt piliation based on electron microscopy, the mutation has
a much less dramatic affect on transformation frequency. Taken together, these data suggest
that the pilQ2 mutation results in PilQ complexes that are not functional for pilus assembly,
but retain the partial ability to facilitate DNA transformation. It is possible that the pilin-
expressing membraneous projections provide a means for transforming DNA to enter the
bacterial cell.
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Effect of the pilQ2 mutation on PilQ oligomerization
To understand the effects of the pilQ2 mutation on PilQ, we analyzed cell lysates from PR100
and PR100 pilQ2 by SDS-PAGE and Western blotting with a PilQ antibody. As shown in Fig.
3A, PilQ from PR100 migrated at two positions: at the top of the gel, which corresponds to an
SDS-resistant high-molecular-mass (HMM) multimer (Drake et al., 1997) (most likely a
dodecamer (Collins et al., 2001;Collins et al., 2004)), and at 75 kDa, which corresponds to a
PilQ monomer. In contrast, PilQ from PR100 pilQ2 showed no evidence of the SDS-resistant
multimer, but instead migrated as a band at 75 kDa with increased amounts of PilQ breakdown
products. PR100 with a disrupted pilQ gene (pilQ::Ω), in which the Ω fragment encoding
spectinomycin resistance (Prentki and Krisch, 1984) replaced codons 266 to 367 of the pilQ
gene (Chen et al., 2004), showed a complete loss of PilQ protein (Fig. 3A). We also tested the
effects of temperature on the capacity of the mutant PilQ to resist denaturation by SDS.
However, no HMM PilQ multimer was observed regardless of the temperature at which the
samples in SDS-PAGE loading buffer were incubated before electrophoresis (Fig. 3B).
Next, we investigated whether the pilQ2 mutation interfered with transport of PilQ subunits
to the outer membrane, where it is assembled into SDS-resistant HMM oligomers, or whether
it interfered with oligomer assembly directly. Outer membranes were isolated (Heckels,
1977) and subjected to SDS-PAGE and Western blotting. As shown in Fig. 3C, a banding
pattern for PilQ essentially identical to whole cell lysates was observed in each strain,
suggesting that the PilQ mutant protein is transported to the outer membrane but is not present
as an SDS-resistant HMM oligomer.
To determine in more detail the effects of the pilQ2 mutation on the oligomeric structure of
pilQ in the bacterial envelope, we extracted total membranes from FA19 and FA19 pilQ2 with
the zwitterionic detergent SB-10 and fractionated the extracts by gel filtration. The levels of
PilQ oligomer (FA19) and monomer (FA19 pilQ2) from individual fractions were assessed by
Western blotting and densitometry (Fig. 3D). In the wild type cells, the SDS-resistant PilQ
oligomer eluted as a broad peak at a position consistent with its predicted molecular mass
(∼1 MDa). Interestingly, PilQ protein from FA19 pilQ2 was found in two distinct peaks: the
first peak eluted at the same position as the PilQ oligomer, whilst the second more prominent
peak eluted with an approximate molecular mass of ∼200 kDa. Although larger than the mass
of a PilQ monomer (75 kDa), this latter peak eluted at the same position as the SDS-sensitive
PilQ monomer present in wild type cells (data not shown). This peak potentially represents the
trimer structure of meningococcal PilQ reported by Collins et al. (Collins et al., 2004). These
results strongly suggest that a fraction of the Glu-666 to Lys mutant of PilQ exists in the
membrane in an oligomeric form, but the mutation prevents its maturation into an SDS-resistant
form.
Finally, because we did not observe any pilin fibers in the pilQ2 or pilQ::Ω strains, we
examined the level of pilin proteins in whole cells by Western blot analysis (Fig. 3E). The total
amounts of pilin in RM11.2 recA6, RM11.2 recA6 pilQFA19, RM11.2 recA6 pilQ2, and
RM11.2 recA6 pilQ::cat were very similar. The biggest difference between the individual
strains was observed in the band corresponding to the proteolytic breakdown product, S-pilin.
Compared to RM11.2 recA6, the small portion of pilin migrating as S-pilin was ∼2-fold higher
in RM11.2 recA6 FA19 pilQ, whereas the amount of S-pilin in RM11.2 recA6 penC and
RM11.2 recA6 pilQ::cat was ∼2-fold lower (Fig 3E). Thus, the pilQ2 mutation had no
significant effects on the total levels of pilin, but appeared to cause a modest decrease in the
levels of the minority S-pilin form.
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Effect of pilQ2 on antibiotic resistance
To further investigate the effect of pilQ2 on gonococcal antibiotic resistance, we generated
strains with various combinations of resistance genes in concert with either the pilQ2 or
pilQ::Ω allele. When either pilQ2 or pilQ::Ω was introduced into FA19, FA19 penA, or FA19
penA mtrR, no increase in the MIC of penicillin or tetracycline was observed (Fig. 4, left
panels). In contrast, introduction of either of the two pilQ alleles into PR100 (FA19 penA mtrR
penB) or FA6140, a high level penicillin-resistant CMRNG isolate (Danielsson et al., 1986),
conferred a 2- to 3-fold increase in the MICs for penicillin and tetracycline (Fig. 4, middle
panels). The levels of resistance conferred by pilQ2 were essentially identical to those conferred
by pilQ::Ω. Acquisition of pilQ2 by strains with only one of the two resistance determinants
mtrR or penB was not sufficient to confer resistance to penicillin, consistent with previous data
demonstrating that penB is unable to increase resistance to penicillin in the absence of mtrR
(Olesky et al., submitted; (Sparling et al., 1975; Veal et al., 2002). In contrast, acquisition of
pilQ2 by a strain harboring both mtrR and penB resulted in increases in both penicillin and
tetracycline resistance (Fig. 4, right panels).
To examine the specificity of the effect of PilQ on the influx of antibiotics, we determined the
MICs of a variety of antibiotics for PR100 and PR100 pilQ2 (data not shown). The MICs of
ampicillin, ceftriaxone, and ciprofloxacin each increased ∼1.5- to 2-fold in PR100 pilQ2
compared to PR100, suggesting that these antibiotics readily enter the cell in a PilQ-dependent
manner. In contrast, rifampin, chloramphenicol, and erythromycin showed much more modest
increases (∼1.2-fold) in their MICs for PR100 pilQ2 compared to PR100. Thus, PilQ promotes
the entry of a range of antibiotics into the bacterial cell, although there is some preference for
hydrophilic antibiotics.
The role of Type IV Pilus accessory subunits in conferring penicillin resistance
Since the only known role for PilQ in the gonococci is for pilus assembly, we investigated the
role of several accessory proteins involved in type IV pilus biogenesis on antibiotic sensitivity.
We introduced deletions of pilT, pilE, and pilP into SZ3 (RM11.2 penA mtrR penB), which
has a normal pilQ allele, and determined the MIC of penicillin in each of these strains (Fig. 5).
Pilin proteins form the pilus fiber that requires PilQ for expression outside of the bacterial cell
(Wolfgang et al., 2000), and we examined whether the presence of pilin fibers might influence
the entry of penicillin into the periplasm. A ΔpilE mutant showed only a small increase in
penicillin resistance, indicating that pilin fibers neither interfere nor assist with antibiotic
diffusion into the periplasm. We also examined whether the pilus retraction-associated ATPase,
PilT (Maier et al., 2002;Merz et al., 2000), was involved in helping penicillin enter the cell.
When the pilT::erm allele was introduced into SZ3, no change in resistance was observed,
demonstrating that pilus retraction is not involved in the entry of penicillin. Finally, we
examined the role of PilP, which has been reported to influence PilQ multimerization (Drake
et al., 1997), in altering antibiotic resistance. Deletion of the pilP gene in SZ3 resulted in
decreased levels of multimeric PilQ in whole-cell lysates by Western blotting, while the levels
of PilQ monomer were similar to those of the parent strain (data not shown). The MIC of
penicillin for SZ3 ΔpilP increased, but the level of resistance was lower than that observed for
SZ3 pilQ2 or SZ3 pilQ::Ω (Fig. 5). These data confirm that deletion of PilP decreases the
amount of the SDS-resistant PilQ complex in the outer membrane, and, similar to the pilQ2
point mutation, results in a decrease in penicillin entry and a subsequent increase in resistance.
Random mutagenesis of Glu-666
To investigate in more detail the importance of Glu-666 in formation of an SDS-resistant PilQ
oligomer, we randomized the codon for Glu-666 in the wild type pilQ gene and transformed
SZ3 to increased penicillin resistance. The pilQ gene was amplified from resistant colonies,
and those genes with a silent NsiI site, which was present only in the randomized clones, were
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chosen for further analysis (Table 2). Sequencing of the pilQ genes from these colonies and
subsequent Western blotting (data not shown) showed that substitution of Glu-666 with almost
any uncharged polar or nonpolar amino acid resulted in the same phenotype as pilQ2: i.e.
increased penicillin resistance (to the same level as pilQ2; Table 2) and inhibition of formation
of SDS-resistant PilQ oligomers (data not shown). To our surprise, we did not identify the
original Glu-666 to Lys mutation of pilQ2 in our random screening, nor did we identify any
acidic, amide, or other basic residues. To investigate whether these three classes of amino acids
were capable of substituting for Glu-666, we employed site-directed mutagenesis to change
Glu-666 to Asp, Arg, or Gln. Transformation of SZ3 with the individual mutant plasmids
revealed that only the Glu-666 to Arg mutation gave rise to penicillin-resistant colonies with
frequencies above controls. The Glu-666 to Arg mutation also interfered with formation of the
HMM PilQ multimer as determined by Western blotting (data not shown). These data
demonstrate that only acidic or amidated amino acids are capable of replacing Glu-666 and
allowing formation of the SDS-resistant PilQ multimer. Moreover, alignment of N.
gonorrhoeae PilQ near the region of Glu-666 with several of the most homologous PilQ
secretins from other bacterial species revealed that the amino acid in the same position as
Glu-666 was either Glu, Asp, or Asn (Fig. S1), suggesting that this residue may play an
important role in other secretins as well.
Importance of Cys-644 and Cys-653 in PilQ oligomerization
Early studies on PilQ (then named OMC or OMP-MC) revealed that the high molecular mass
complex of PilQ obtained on SDS-PAGE could be converted quantitatively to a single 75 kDa
subunit on SDS-PAGE following reduction and alkylation (Hansen and Wilde, 1984; Newhall
et al., 1980). There are only two cysteine residues in FA1090 and FA19 PilQ, Cys-644 and
Cys-653, both of which are relatively close to the site of the pilQ2 mutation described herein.
To determine whether mutation of these two cysteine residues would also alter PilQ properties,
we mutated the codons for the two cysteine residues of PilQ to serine either individually or
together and transformed the mutant genes into strain SZ3. Strikingly, strains containing
pilQ mutations of either cysteine (or both) resulted in a very similar phenotype as SZ3 pilQ2.
Western blots of PilQ showed the complete absence of the high molecular mass dodecamer,
increased levels of the monomer subunit (Fig. 6A), and identical MICs of penicillin compared
to SZ3 pilQ2 (Fig. 6B). Transformation competence of SZ3 containing the pilQ cysteine
mutants also was decreased to a similar extent as SZ3 pilQ2 (data not shown). As expected,
strains harboring the mutant cysteine pilQ alleles displayed a non-piliated colony morphology.
These data indicate that cysteine mutations prevent formation of an SDS-resistant PilQ
complex and affect antibiotic resistance to the same extent as pilQ2.
DISCUSSION
In the search for genes involved in high-level penicillin resistance (MIC ≥ 2 μg/ml), we
identified in PR100 a spontaneously arising resistance determinant, termed penC, that
conferred an increase in both penicillin and tetracycline resistance, suggesting that penC alters
the general permeability of antibiotics (Ropp et al., 2002). We show here that penC results
from a point mutation in the pilQ gene (pilQ2), which changes Glu-666 to Lys and prevents
formation of an SDS-resistant high-molecular-mass multimer of PilQ without altering the
levels of PilQ in the cell. These observations suggest that the PilQ secretin can facilitate the
entry of small molecules into the bacterial cell in addition to its more well-defined role in pilin
biogenesis and DNA transformation.
Two major models can account for our results. The most straightforward model is that
antibiotics enter the periplasm through the pore made by the PilQ multimer and that the
pilQ2 mutation blocks entry by destabilizing the pore. This model is consistent with reports
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that the pIV and PulD secretins function as gated pores when reconstituted into planar lipid
bilayers (Marciano et al., 1999; Nouwen et al., 1999). In addition, the structure of
meningococcal PilQ obtained by cryo-transmission electron microscopy (Collins et al.,
2003) reveals a central cavity 65 Å in diameter at the largest end that tapers to a closed point
at the other end, which needs to open to allow the pilus to transverse the outer membrane. This
structure is consistent with the idea that PilQ, much like pIV and PulD, can function as a pore
through which antibiotics diffuse into the periplasm.
The second major model is that the presence of a nonfunctional PilQ in the outer membrane
alters the function of porin or the MtrC-MtrD-MtrE efflux pump, leading to a decrease in
antibiotic entry or an increase in antibiotic efflux respectively. However, we believe this second
model is unlikely for several reasons. First, both the pilQ2 and pilQ::Ω alleles had identical
effects on penicillin resistance when introduced into PR100 or SZ3, even though in a pilQ2
strain the protein is still present in the outer membrane while in a pilQ::Ω strain it is absent.
Secondly, neither pilQ2 nor pilQ::Ω had any effect on penicillin or tetracycline resistance when
introduced into strains containing the mtrR or penB gene alone (Fig. 4). Finally, the pilQ2
mutation appears to increase resistance to hydrophilic antibiotics more than to hydrophobic
antibiotics, which is opposite of what would be expected if the pilQ2 mutation increased the
activity of the MtrC-MtrD-MtrE efflux pump (the pump shows preferences for hydrophobic
agents and antibiotics; (Hagman et al., 1995)). Taken together, our data are most consistent
with the idea that the PilQ secretin forms a pore across the outer membrane that allows the
diffusion of antibiotics into the periplasm.
The model of PilQ as a pore-forming protein is also consistent with a previous study
investigating heme import into N. gonorrhoeae (Chen et al., 2004). In that study, the authors
identified several classes of spontaneously arising colonies of FA1090 harboring a deletion in
the hemoglobin receptor protein HpuA that were capable of utilizing hemoglobin as the sole
source of iron and porphyrins. One class of such mutants contained a F595L mutation in the
pilQ gene (pilQ1), which appeared to alter the pore formed by the PilQ multimer to allow the
diffusion of free heme released from hemoglobin into the cell. The pilQ1 mutation also
increased antibiotic sensitivities to several antibiotics and Triton X-100, reinforcing the idea
that a measurable influx of antibiotics can occur through the PilQ secretin complex.
Interestingly, the pilQ1 mutation required the pilus-associated ATPase, PilT, for growth on
hemoglobin, while we have shown that increase of penicillin resistance conferred by the
pilQ2 mutation is PilT-independent (Fig. 6). This difference may reflect different processes,
however, as the heme must enter into the cytoplasm to support growth, whereas penicillin need
only diffuse into the periplasm. Indeed, Chen et al. (2004) showed that increased sensitivity to
ampicillin in the pilQ1 strain was not dependent on PilT.
Other studies have documented the effects of mutations and/or insertions in secretins on outer
membrane permeability. For example, Wall et al. (Wall et al., 1999) characterized a mutant
allele of Myxococcus xanthus pilQ, which is involved in pilin biogenesis and social motility
in this organism. The mutant allele contained two missense mutations (G741S and N762G) in
its C-terminus that conferred hypersensitivity to vancomycin. Similarly, Russel (Russel,
1994) identified mutants in the pIV secretin involved in export of the filamentous phage f1 that
conferred hypersensitivity to both vancomycin and deoxycholate. These pilQ mutants therefore
resemble the F595L mutation characterized by Chen et al. (Chen et al., 2004) in that the
alterations increased the susceptibility of the organism to antibiotics and deoxycholate,
presumably by increasing the size of the PilQ channel or by changing the conformation of a
region that constricts the channel. Interestingly, alignment of the PilQ secretins from M.
xanthus and N. gonorrhoeae shows that one of the two mutations in the mutant M. xanthus
pilQ allele (N762G) maps to within seven residues of Phe-595 of gonococcal pilQ1 (Chen et
al., 2004), whereas the other mutation is ∼25 amino acids distant (data not shown). The similar
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location of these mutants in PilQ homologues suggests that this area is involved in defining
the size of the PilQ channel.
In contrast to these other studies, in which mutations increased the sensitivity of the strain to
antibiotics and detergents, the mutations in gonococcal PilQ characterized here increase
resistance provided that at least mtrR and penB are present. The pilQ2 mutation also prevents
formation of an SDS-resistant PilQ oligomer, but the direct cause and effect of these two
observations has yet to be established. To our knowledge, this is the first report of a mutation
in PilQ from Neisseria that interferes with formation of an SDS-resistant HMM multimer,
although a recent report showed that deletion of the presumed chaperone protein, PilW, also
resulted in the loss of the SDS-resistant PilQ multimer (Carbonnelle et al., 2005). While the
actual effect of the pilQ2 mutation on PilQ structure is unclear, gel filtration of wild-type and
mutant PilQ proteins (Fig. 3D) suggests that at least a portion of the PilQ protein in the
pilQ2 mutant exists as a oligomeric species (presumably, like the wild-type, a dodecamer).
These results suggest that the pilin-expressing membraneous projections in FA19 pilQ2
observed by immunoelectron microscopy (Fig. 1B) may be the result of this oligomeric PilQ
interacting with pili and could explain the high residual transformation competence of the
pilQ2 strain (Fig. 2). However, if present these PilQ complexes are unable to facilitate the
diffusion of antibiotics across the outer membrane. More knowledge about how pilQ assembles
and interacts with the pilus assembly proteins will be required before a detailed molecular
understanding of the effect of the effect of these mutations on the entry of DNA and antibiotics
into the bacterial cell is known.
Type IV pilin biogenesis in N. gonorrhoeae requires multiple accessory subunits in addition
to pilin and PilQ (Wolfgang et al., 1998; Wolfgang et al., 2000). Thus, we also examined the
role of pilin, PilT, and PilP in antibiotic resistance by creating deletion mutants in SZ3, a 3rd
level transformant of RM11.2 recA6 with a wild type pilQ allele (Fig. 5). The lack of a
substantial increase in penicillin resistance in SZ3 following deletion of the pilE or pilT gene
shows that neither assembly or disassembly of the pilus fiber alters the ability of PilQ to enable
penicillin entry, even though structural modeling suggests that a pilin fiber would fully occupy
the central cavity of PilQ (Collins et al., 2003). In contrast, penicillin resistance in SZ3
ΔpilP increased significantly, although not to the same level as the pilQ2 mutation. Because
deletion of PilP decreased the expression of the multimeric form of PilQ without changing the
levels of the monomeric form (data not shown; (Drake et al., 1997)), our data suggest that the
intermediate increase in resistance is the result of a decrease in the number of stable PilQ
multimers in the outer membrane. The simplest model to account for all of these observations
is that only some of the PilQ complexes are dedicated to expressing pili, but that all PilQ
complexes are influenced by expression of PilP. This model predicts that different complexes
of pilQ are involved in different functions in the outer membrane and that the decreased
multimeric form detected in gonococcal membranes of a pilP strain may explain the differential
phenotypes of the pilQ2 mutation.
One of the intriguing aspects of chromosomally mediated resistance is that the resistance
determinants must be transferred in a specific order. For example, our results demonstrate that
pilQ2 does not increase the MIC of penicillin or tetracycline unless other resistance
determinants are present (Fig. 4). Of the previously described resistance determinants, only
mtrR and penB are necessary for pilQ2 to increase resistance to penicillin or tetracycline (Fig.
4, right panels). The penA gene further increases resistance, but its presence is not required for
the phenotypic increase in resistance mediated by pilQ2 (Fig. 4). The fact that pilQ2 has no
influence on the MIC unless other resistance determinants are present that reduce the
concentration of antibiotics in the periplasm (mtrR and penB) suggests that influx of antibiotics
through the PilQ multimer in susceptible strains is only a small fraction of the antibiotic influx
compared to that through porin. Only when mtrR and penB combine to decrease influx through
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porins does the influx of antibiotics through PilQ become significant, thereby increasing
resistance when PilQ is deleted or mutated (see Figure 8). Because this mutation disrupts
normal piliation, increases in resistance as a result of pilQ mutations are unlikely to be observed
in the clinical setting owing to the importance of pili in mucosal infections (Hamrick et al.,
2001;Swanson, 1973), although pilQ mutations may have a role in resistance in disseminated
infections in which the role of pili is not well established. Nonetheless, our results underscore
the role of the PilQ secretin in the diffusion of antibiotics and other molecules into the periplasm
of the bacterium.
MATERIALS AND METHODS
Bacterial strains and plasmids
FA19 (Maness and Sparling, 1973) is a penicillin-susceptible laboratory strain. FA6140 is a
high-level chromosomally mediated resistant strain of N. gonorrhoeae isolated in Durham in
the 1970's (Danielsson et al., 1986). RM11.2 recA6 (Seifert, 1997) is a derivative of FA1090
(Dempsey et al., 1991) containing the recA gene under regulation of the lac operator/promoter.
Other strains used in this work are described in Table 1. Transformations with FA19 strains
were carried out exactly as described previously (Ropp et al., 2002). Transformations of
RM11.2 recA6 were similar except that 1 mM IPTG was added to the cells before exposure to
DNA to allow for the expression of the recA gene product required for homologous
recombination (Seifert, 1997). Selection for the penA4, mtrR, and penB5 stepwise
transformants in RM11.2 recA6 was carried out on GCB plates with 0.04 μg/ml penicillin G,
2 μg/ml erythromycin, and 0.28 μg/ml penicillin G respectively. SZ3 ΔpilE was constructed
by transforming SZ3 with genomic DNA from a strain of FA1090 with a complete deletion in
the pilE gene (kindly provided by Dr. Janne Cannon, UNC-Chapel Hill) and selecting for
nonpiliated colonies.
In order to generate cell lines harboring the pilQ2 mutation, we constructed a plasmid (pUC18-
pilQ2-kan) containing the last 864 bp of FA19 pilQ2 (encoding residues 445-731), the
kanamycin phosphotransferase gene inserted 20 bp past the pilQ stop codon, and 280 bp of
additional downstream sequence, and used this plasmid to transform the various recipient
strains to kanamycin resistance. A silent NsiI site was created by changing T to G at nucleotide
1959 of the FA19 pilQ2 gene to aid in identifying transformants containing the pilQ2 mutation.
To generate strains with a disrupted pilQ allele (pilQ::Ω), strains were transformed with
pUNCH290 (Chen et al., 2004). pUNCH290 comprises nucleotides 434 of the FA1090 pilQ
gene to 152 bp downstream of the stop codon, in which an internal HincII fragment was
replaced with the Ω fragment conferring spectinomycin resistance (Prentki and Krisch,
1984). All strains were verified by PCR amplification and sequencing, and by Western blotting
to verify the absence of the high molecular mass PilQ oligomer (pilQ2 strains) or PilQ reactivity
(pilQ::Ω).
Growth conditions and MIC determinations
N. gonorrhoeae were grown on GCB plates with Supplements I and II (Kellogg et al., 1963)
at 37°C in a humidified 5% CO2 atmosphere, and E. coli were growth on LB plates or in 2X
YT media (Sambrook et al., 1989) as described (Ropp et al., 2002). MICs were determined by
the spot method as described (Ropp et al., 2002). Briefly, cells were resuspended at a density
of 1 × 107 cells/ml and 5 μl (50,000 colonies) were spotted onto GCB agar plates containing
increasing concentrations of the appropriate antibiotics. The MIC was defined as the lowest
concentration at which no more than 5 colonies grew following incubation for 24 hr. MICs
were determined for multiple transformants and represent the average ± S.E.M of at least three
independent experiments.
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Cloning the pilQ2 gene
Chromosomal DNA from PR100 penC (Ropp et al., 2002) was digested with ClaI, separated
on a 0.7% agarose gel, and ten fractions ranging in size from 12 kb to 300 bp were tested for
their ability to transform PR100 to penicillin resistance on GCB with 1.2 μg/ml penicillin.
Fraction 2, comprising fragments from ∼ 8 to 10 kb, was enriched in the pilQ2 gene and was
used to create a mini-library in ClaI-digested pBeloBac 11 bacmid vector (Kim et al., 1996).
Initial attempts to clone the gene into the medium copy-number plasmid pACYC184 were
unsuccessful, necessitating the use of the single copy-number bacmid vector. Three clones
were found to transform PR100 to penicillin resistance with high frequency. Each clone
harbored an identical 10.6 kb insert containing seven genes: the 3′-end of pilQ, aroK, aroB,
yafJ, and three hypothetical genes of unknown function. The location of the penC gene was
narrowed down by amplifying each gene and testing the fragments in the transformation assay.
Only the fragments containing the pilQ gene transformed PR100 to higher penicillin resistance
with high frequency, demonstrating that the penC mutation maps to the 3′-end of the pilQ gene
(bp 1333-2196 encoding residues 445-731). All three clones revealed the identical basepair
mutation.
Immunoelectron microscopy of pilin fibers
Analysis of the piliation states of gonococcal strains was determined exactly as described
previously (Chen et al., 2004). The C-terminal domain of FA19 PilQ differs from FA1090
PilQ by two amino acid differences (G523R and N620S). To ensure that sequences of PilQ
had no bearing on the piliation state of the gonococci, the C-terminal domain of pilQ from
RM11.2 recA6 (an FA1090 dertivative) was also exchanged with the corresponding region
from FA19. A plasmid identical to the one used to transfer the pilQ2 allele into strains (see
above), except that it contained the wild type sequence from FA19, was used to construct
RM11.2 recA6 pilQFA19.
Transformation efficiency
Strains were passaged on GCB agar plates, resuspended in GCB with supplements I and II, 20
mM NaHCO3, 10 mM MgCl2 and 1 mM IPTG (GCB+), and diluted to OD600 = 0.18 in the
same medium. Twenty μl of cells and 100 ng of pSY6 were added to 180 μl of GCB+ and
incubated at 37°C in 5% CO2/95% air for 15 min. GCB+ (1.8 ml) was then added and the cells
were incubated for a further 5 hrs, followed by serial 10-fold dilutions in GCB+. A portion (50
μl) of the appropriate dilution was plated in duplicate on GCB + 2 μg/ml nalidixic acid (NAL)
plates. For determination of total CFU, 50 μl of a 1 × 104 dilution were plated on GCB plates.
Electrophoresis and Western blotting
For SDS-PAGE and Western blotting of whole cell lysates, cells were swabbed from GCB
plates, resuspended in GCB+ at an OD560 of 0.18, and 1 ml was removed to a microfuge tube.
After pelleting the cells and removal of the medium, 100 μl of SDS-PAGE loading buffer was
added and the cells were dispersed. Three to ten μl of the samples were loaded onto SDS-
polyacrylamide gels (8 or 10%) and separated by electrophoresis. The proteins in the gel were
then electrotransferred to nitrocellulose filters overnight in 25 mM Tris, 192 mM glycine, and
10% methanol. The lower methanol appeared to increase the efficiency of transfer of the high
molecular mass PilQ oligomer. Following transfer, the filter was blocked with 5% dry milk in
phosphate-buffered saline with 0.1% Tween (PBS-T), then incubated with a 1:10,000 dilution
of a PilQ antibody (kindly provided by Charles E. Wilde III, Indiana University School of
Medicine) for 2 hrs at 25°C. The filter was washed 3 times with PBS-T, and incubated for
another 1 hr with HRP-conjugated mouse anti-rabbit secondary antibody (Amersham
Biosciences, Piscataway, NJ). After washing the filter, PilQ bands were visualized with
SuperSignal West Pico (Pierce Chemical Co., Rockford, IL).
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For pilin blots, cells were prepared as described above, checked for protein levels to ensure
equal loading, and separated on 15% SDS-polyacrylamide gels. Proteins were transferred from
gels to PVDF membranes, and membranes were blocked with 5% dry milk in Tris-buffered
saline with 0.1% Tween. The membranes were probed with the pilin monoclonal antibody 1E8/
G8 (gift from M. Koomey and M. Blake), washed, incubated with HRP-conjugated goat anti-
mouse secondary antibody (Roche Molecular Biochemicals), and washed again. The ECL Plus
Western Blot kit (Amersham Biosciences) was used to detect pilin bands.
Gel Filtration of PilQ proteins
Liter cultures of FA19 (wild-type PilQ) and FA19 pilQ2 (PilQ-E666K) were grown in GCB
broth with Supplements B, I and II, and 10 mM sodium bicarbonate. Cells were pelleted, lysed
with an EmulsiFlex-C5 homogenizer (Avestin, Ottawa, Canada), and membranes were isolated
by centrifugation at 100,000g. The membrane pellets were dounce-homogenized in Buffer A
(20 mM Tris, 150 mM NaCl, 2 mM EDTA, pH 8.0), mixed with an equal volume of 40 mM
Tris, 4% SB-10, 3 M NaCl, 2 mM EDTA, pH 8, and incubated on ice for 1 h. The membranes
were pelleted at 15,000g for 30 min, and the supernatants containing the extracted PilQ proteins
were filtered through 0.45μm filters. Aliquots (300 μl) were submitted to gel filtration on a
Sephacryl S-500 column (16 mm × 70 cm) in 20 mM Tris, pH 8, 500 mM NaCl, 1 mM EDTA,
1.2% SB-10. Twenty μl from the indicated fractions were processed for SDS-PAGE and
Western blotting, and the resulting bands were imaged on a Bio-Rad Fluoro-S system and
quantitated with QuantityOne software (Bio-Rad, Hercules, CA).
Site-directed and site-saturation mutagenesis of pilQ
To generate a library of pilQ fragments in which the codon for Glu-666 was randomized, we
utilized overlap-extension PCR (Ho et al., 1989). The sense mutagenic primer (5′-
TGAATACGCAGGCTATGGTTNNNAACGGCGGCACTTTGATTG-3′) comprised 20 bp
at the 5′ end of codon-666, three random bases, and 19 bp at the 3′ end of codon-666, while
the antisense mutagenic primer (5′-AACCATAGCCTGCGTATTCA-3′) comprised the
reverse complement of the first 20 bp of the sense primer. The template was a plasmid vector
(pUC18) containing a portion of the pilQ gene starting at 1333 bp to 300 bp downstream of
the stop codon. In the first set of reactions, a sense (relative to the direction of pilQ) vector
primer and the antisense mutagenic primer or the sense mutagenic primer and an antisense
vector primer were used to amplify the same template in separate amplifications. The resulting
fragments were isolated, combined, and the full-length pilQ gene with a randomized codon at
position-666 was generated in a second PCR reaction with only the vector primers. The
mutagenized PCR fragments were purified on a Marligen (Gaithersburg, MD) PCR purification
column and used to transform PR100 to penicillin resistance. Resistant colonies were passaged,
examined by western blotting to determine clones expressing only the monomeric PilQ subunit,
and the pilQ gene from those clones were amplified from genomic DNA and sequenced to
determine the identity of the mutation. Site-directed mutagenesis was carried out with the same
template described above using the QuickChange kit from Stratagene (La Jolla, CA).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Electron micrographs of immunogold-labeled pili from strain RM11.2 recA6 with
different pilQ alleles
(A) RM11.2 recA6 (left panel), RM11.2 recA6 pilQFA19 (middle panel), and RM11.2 recA6
pilQ2 (right panel) were constructed as described in Materials and Methods. Strains were grown
on GCB plates and colonies were lifted directly onto Formavar-coated grids. Pili were detected
with an anti-pilin antibody and detected with a gold-conjugated secondary antibody as
described previously (Long et al., 2003). Whereas most of the RM11.2 recA6 pilQ2 cells were
as shown in the right panel of (A), a small number of cells had small projections that were
labeled with the anti-pilin antibody (B).
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Figure 2. Transformation competence of SZ3 (RM11.2 recA6 penA mtrR penB) and SZ3 with
pilQ2, pilQ::Ω, pilE, or pilT::erm alleles
The indicated strains were prepared as described in Materials and Methods and incubated with
100 ng of pSY6, which confers resistance to nalidixic acid (NALr), for 5 hrs before plating.
The transformation efficiency is expressed as the number of NALr transformants per CFU. The
dotted line represents the lowest transformation efficiency that was measurable. The average
± S.D. for three independent experiments is shown.
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Figure 3. Western blots of PilQ from strains with wild type and pilQ2 alleles
Western blots of whole cell lysates (A, B) or outer membranes (C) probed with a polyclonal
antibody against PilQ. The large arrow indicates the SDS-resistant high-molecular-mass PilQ
multimer, whereas the small arrow indicates the PilQ monomer. In panels (A) and (C), samples
in SDS-loading buffer were incubated at 100°C for 5 min before loading, while in panel (B),
samples were treated for 5 min at the indicated temperature before loading. The outer
membranes in (C) were prepared as described by Heckels (1977). In panel (D), proteins from
FA19 (left) or FA19 pilQ2 (right) membranes extracted into SB-10 were submitted to gel
filtration on Sephacryal S-500. The elution of PilQ oligomer (left graph) and total PilQ (right
graph) was assessed by quantitation of Western blots as described in Materials and Methods.
The arrows at the top denote the positions of protein standards (MWs are listed above the
arrows). In panel (E), Western blots of whole cell lysates were probed with a monoclonal
antibody directed against the pilin protein. Percentage of total pilin protein (RM11.2 recA6
taken as 100%) and S-pilin (reported as the % of total pilin in that lane) were determined by
densitometry and are listed below each lane.
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Figure 4. Penicillin and tetracycline resistance of strains containing wild type, pilQ2, and pilQ::Ω
alleles
FA19 harboring various combinations of the penA (mutations in PBP 2), mtrR (increased
expression of the MtrC-MtrD-MtrE efflux pump) and penB (mutations in porin; see Table 1
for more information) resistance determinants was transformed with plasmids encoding mutant
(pilQ2) and inactivated pilQ (pilQ::Ω) alleles and the MICs of penicillin G and tetracycline
for the resulting strains were determined as described in Materials and Methods. pilQ2 and
pilQ::Ω were also introduced into FA6140, a chromosomally mediated penicillin-resistant
clinical isolate (Danielsson et al., 1986). *P<0.01 relative to the parental strain.
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Figure 5. MICs of penicillin for SZ3 with deletions in Type IV pilus-associated genes
SZ3 (RM11.2 recA6 penA4 mtrR penB5; see Table 1) was transformed with plasmids or
genomic DNA containing inactivated or deleted alleles of pilT, pilE and pilP, and the MICs of
penicillin for multiple colonies from each transformation and for SZ3 pilQ2 and SZ3
pilQ::Ω were determined as described in Materials and Methods. *P<0.01 relative to the
parental strain.
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Figure 6. Effects of Cys to Ala mutations in PilQ when expressed in SZ3
Cys-643 and Cys-654 were changed individually or together to Ser and the mutant alleles were
transformed into SZ3. (A) Western blots of PilQ in whole cell lysates. (B) MICs of penicillin
for SZ3 with wild type (parental) and the indicated mutant pilQ alleles.
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Figure 7. Model showing why the pilQ2 and pilQ::Ω alleles increase resistance only in strains also
harboring mtrR and penB mutations
The two panels show a schematic representation of the cell envelope of N. gonorrhoeae. Left
panel, FA19. In this strain the entry of penicillin through porin is much greater than the entry
through the PilQ complex. The low level of the MtrC-MtrD-MtrE efflux pump is represented
by light shading. Right panel, PR100. This strain has acquired penA, mtrR, and penB resistance
determinants, resulting in the expression of altered forms of PBP 2 and porin IB and
overexpression of the MtrC-MtrD-MtrE efflux pump. The mtrR and penB determinants
function to lower the influx of penicillin through porin such that entry of penicillin through the
PilQ complex becomes a significant portion of the total influx. Only in PR100 will functional
deletion of the PilQ complex (due to pilQ2 or pilQ::Ω) lead to increase resistance to penicillin.
See text for details.
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Table 1
Strains and plasmids used in this study
Strain or plasmid Descriptiona Reference
pUC18-pilQ2-kan Plasmid containing bp 1333-2196 of pilQ2, a kan resistance
cassette, and an additional 300 bp of downstream sequence
This study
pUC18-pilQFA19-kan Same as above without the mutation at Glu-666 This study
pUNCH290 Plasmid containing pilQ disrupted by the Ω fragment (Chen et al., 2004)
pMO/porIB-G120K-erm Plasmid containing the mature coding sequence of PIB with
a G120K mutation, an erm resistance cassette, and
additional 300 bp of downstream sequence
(Olesky et al., 2002)
pSY6 Plasmid containing gonococcal DNA fragment encoding
nalidixic acid resistance
(Stein et al., 1991)
FA19 Penicillin-susceptible laboratory strain (Maness and Sparling, 1973)
FA6140 Penicillin-resistant clinical isolate (Danielsson et al., 1986)
FA19 penA4 FA19 × FA6140 DNA (0.03 μg/ml penb) (Ropp et al., 2002)
FA19 penA4 pilQ2 FA19 penA4 X pUC18-pilQ2-kan (50 μg/ml kan) This study
FA19 penA4 pilQ::Ω FA19 penA4 X pUNCH290 (100 μg/ml spt) This study
FA19 penA4 mtrR FA19 penA4 X FA6140 DNA (1 mg/ml Triton X-100) (Ropp et al., 2002)
FA19 penA mtrRpilQ2 FA19 penA4 mtrR X pUC18-pilQ2-kan (50 μg/ml kan) This study
FA19 penA mtrR pilQ::Ω FA19 penA4 mtrR X pUNCH290 (100 μg/ml spt) This study
FA19 penB FA19 X pMO/porIB-G120K-erm (6 μg/ml erm) This study
FA19 penB pilQ2 FA19 penB X pUC18-pilQ2-kan (50 μg/ml kan) This study
FA19 mtrR penB FA19 mtrR X porIB-G120K-erm (6 μg/ml erm) This study
FA19 mtrR penB pilQ2 FA19 mtrR penB X pUC18-pilQ2-kan (50 μg/ml kan) This study
PR100 FA19 penA4 mtrR penB5 (Ropp et al., 2002)
PR100 pilQ2 PR100 X pUC18-penC-kan (50 μg/ml kan) This study
PR100 pilQ::Ω PR100 X pUNCH290 (100 μg/ml spt) This study
FA6140 pilQ2 FA6140 X pUC18-pilQ2-kan (50 μg/ml kan) This study
FA6140 pilQ::Ω FA6140 X pUNCH290 (100 μg/ml spt) This study
RM11.2 recA6 FA1090 with IPTG-regulatable recA allele (Long et al., 1998)
RM11.2 recA6 pilQFA19 RM11.2 recA6 X pUC18-pilQFA19-kan (50 μg/ml kan) This study
RM11.2 recA6 pilQ2 RM11.2 recA6 X pUC18-pilQ2-kan (50 μg/ml kan) This study
SZ3 RM11.2 recA6 penA4 mtrR penB5 This study
SZ3 ΔpilE pilE deletion strain of SZ3 This study
SZ3 pilT::erm SZ3 X RM11.2 recA6 pilT::erm (6 μg/ml erm) This study
SZ3 ΔpilP SZ3 X pUC18-ΔpilP (0.5 μg/ml pen) This study
SZ3 pilQ2 SZ3 X pUC18-pilQ2-kan (50 μg/ml kan) This study
SZ3 pilQ::Ω SZ3 X pUNCH290 (100 μg/ml spt) This study
a
Strains were constructed by homologous recombination as described in Materials and Methods and are shown as parental strain X donor DNA (selection
agent). All relevant genotypes were confirmed by DNA sequencing.
b
The abbreviations are: pen, penicillin; kan, kanamycin; spt, spectinomycin; erm, erythromycin.
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Table 2
Site-saturation mutagenesis of codon-666 of PilQ
The amino acids at position-666 of PilQ that increased penicillin resistance and disrupted formation of the SDS-resistant
multimer.
Amino Acid at Position-666 No. Clones Isolated MICpen (μg/ml)














Aspartic Acida Site-directed (0.5)b
Glutaminea Site-directed (0.5)b
a
Constructed by site-directed mutagenesis.
b
Not determined; transformation of SZ3 with pUC18-pilQ E666D or pUC18-pilQ E666Q did not give rise to resistant colonies above negative controls.
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